<DOC>
	<DOCNO>NCT02049983</DOCNO>
	<brief_summary>The purpose study determine Levita Magnetic Grasper Device Safety Performance Laparoscopy .</brief_summary>
	<brief_title>Levita Magnetic Grasper Device Safety Performance Study</brief_title>
	<detailed_description />
	<mesh_term>Gallbladder Diseases</mesh_term>
	<criteria>Patient 18 60 year age Undergoing elective cholecystectomy due : Cholelithiasis ( Gallbladder stone &lt; 2.5cm longer measurement ( length width ) ) Gallbladder polyp assess ultrasound Absence noncorrectable coagulopathy ( INR &lt; 1.4 , platelet count &lt; 50,000/mcl ) Patient body mass index ( BMI ) â‰¤ 35 kg/m2 20 Patient , authorize representative , sign write Informed Consent form participate study , prior study mandate determination procedure Emergency presentation acute gallbladder disease Pancreatitis Jaundice Scleroatrophic gallbladder show ultrasound Biliary tract stone diagnose surgery Acute cholecystitis Gallbladder Empyema Ongoing peritoneal dialysis Previous abdominal surgery laparotomy ( presence previous upper umbilical incision ) Presence umbilical hernia previous umbilical hernia American Society Anesthesiologists ( ASA ) score III IV Patient undergo treatment chronic pain origin Significant comorbidities : cardiovascular , neuromuscular , chronic obstructive pulmonary disease , urological disease ( renal failure ) Patients sign gallbladder perforation diagnose ultrasound Suspicion biliary cancer Patients severe peritonitis Contraindications pneumoperitoneum Known allergy paracetamol NSAIDs Patients metallic implant ( pacemaker , prosthesis , etc ) Previously diagnose suspected history choledocholithiasis base alteration plasma hepatic enzyme Has biliary tract &gt; 7mm size determine ultrasound Has gallbladder wall thickness &gt; 5mm Diabetic Blood coagulation issue Has sign hepatic endocrinology ( i.e : cirrhosis , liver failure , increase liver enzymes , etc . ) History endoscopic papillotomy ( i.e : Preoperative indication endoscopic retrograde cholangiopancreatography ( ERCP ) Patient pregnant wish become pregnant length study participation lactation Patient likely comply followup evaluation schedule Patient participate clinical trial another investigational drug device Patient mentally incompetent prisoner Known suspect drug alcohol abuse Patient systemic infection evidence surgical site infection ( superficial organ space ) Patient compromise immune system autoimmune disease ( WBC &lt; 4000 &gt; 20,000 ) , include prior pending treatment HIV Hep . C Patient intraoperatively need additional surgery undergo elective cholecystectomy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>March 2015</verification_date>
</DOC>